A laboratory in the US is using advanced imaging to decipher the role of a ‘double-agent’ protein in breast cancer, and to help develop drugs targeted at disrupting its function
The technology helping to save young lives by enabling quick testing of patient samples
19th Annual European Society for the Clinical Virology (ESCV) meeting in Lisbon, Portugal, 14-17 September 2016
DxN VERIS Molecular Diagnostics System Showcasing on Booth #52 and at Symposium
Probing the Molecular Details of Drug-Target Protein Interactions Using Microcalorimetry
New test kit is immediately available, has AOAC PTM certification
